HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Margaret H L Ng Selected Research

Sirtuin 2

6/2013SIRT2 overexpression in hepatocellular carcinoma mediates epithelial to mesenchymal transition by protein kinase B/glycogen synthase kinase-3β/β-catenin signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Margaret H L Ng Research Topics

Disease

10Neoplasms (Cancer)
01/2019 - 03/2010
7Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2019 - 07/2004
4Nasopharyngeal Carcinoma
02/2014 - 08/2010
4Carcinogenesis
06/2011 - 03/2007
3Infections
01/2021 - 08/2004
3Severe Acute Respiratory Syndrome
01/2008 - 08/2004
2Leukemia
11/2021 - 12/2011
2Fibrosis (Cirrhosis)
11/2021 - 01/2021
2Stevens-Johnson Syndrome (Lyell's Syndrome)
07/2013 - 05/2007
2Neoplasm Metastasis (Metastasis)
06/2013 - 02/2013
2Hepatocellular Carcinoma (Hepatoma)
06/2013 - 06/2011
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2013 - 08/2006
2Carcinoma (Carcinomatosis)
07/2012 - 08/2010
2Narcolepsy
12/2011 - 07/2007
2Osteoporosis
07/2003 - 03/2003
1Thalassemia
11/2021
1Acute Megakaryoblastic Leukemia (Leukemia, Megakaryocytic)
11/2021
1COVID-19
01/2021
1Hypercalcemia (Milk Alkali Syndrome)
01/2018
1primary familial and congenital Polycythemia
08/2016
1Polycythemia (Erythrocytosis)
08/2016
1Chromosomal Instability (Chromosome Stability)
04/2016
1Genomic Instability
04/2016
1Chromosome Aberrations (Chromosome Abnormalities)
04/2016
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2016
1Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
02/2014
1Hematologic Neoplasms (Hematological Malignancy)
06/2013
1Multiple Myeloma
02/2013
1Residual Neoplasm
01/2013
1Necrosis
12/2011
1Hypoxia (Hypoxemia)
06/2011
1Fever (Fevers)
11/2009
1Exanthema (Rash)
05/2007
1Leukocytosis (Pleocytosis)
08/2006
1Virus Diseases (Viral Diseases)
04/2005
1Thrombocytopenia (Thrombopenia)
04/2005

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
01/2019 - 10/2008
4HLA-B Antigens (HLA-B)IBA
01/2021 - 08/2004
3HLA Antigens (Human Leukocyte Antigens)IBA
12/2011 - 08/2004
2Oxygen (Dioxygen)IBA
08/2016 - 11/2009
2Transcription Factors (Transcription Factor)IBA
04/2016 - 08/2010
2Biomarkers (Surrogate Marker)IBA
01/2016 - 07/2012
2Carbamazepine (Tegretol)FDA LinkGeneric
07/2013 - 05/2007
2CateninsIBA
06/2013 - 12/2011
2Sirtuin 1IBA
06/2013 - 06/2011
2Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
06/2013 - 08/2010
2Platelet Factor 4IBA
02/2013 - 03/2007
2DNA (Deoxyribonucleic Acid)IBA
01/2013 - 06/2011
2Cisplatin (Platino)FDA LinkGeneric
12/2011 - 08/2010
1alpha-TocopherolFDA Link
11/2021
1hemoglobin A2'IBA
11/2021
1Tretinoin (Retinoic Acid)FDA LinkGeneric
11/2021
1IronIBA
01/2021
1VaccinesIBA
01/2021
1RibonucleoproteinsIBA
01/2019
1CreatinineIBA
01/2018
1RNA (Ribonucleic Acid)IBA
12/2017
1Hemoglobins (Hemoglobin)IBA
08/2016
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
08/2016
1hemoglobin TarrantIBA
08/2016
1Messenger RNA (mRNA)IBA
04/2016
1OsteopontinIBA
01/2016
1ThrombinFDA Link
01/2016
1dactolisibIBA
02/2014
1Pharmaceutical PreparationsIBA
07/2013
1NucleotidesIBA
06/2013
1NucleophosminIBA
06/2013
1Glycogen Synthase KinasesIBA
06/2013
1SirtuinsIBA
06/2013
1MicroRNAs (MicroRNA)IBA
06/2013
1Sirtuin 2IBA
06/2013
1ChemokinesIBA
02/2013
1Indicators and Reagents (Reagents)IBA
01/2013
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
07/2012
1WD repeat containing planar cell polarity effectorIBA
12/2011
1Sunitinib (Sutent)FDA Link
12/2011
1Docetaxel (Taxotere)FDA Link
12/2011
1ProdrugsIBA
06/2011
1Free RadicalsIBA
06/2011
1Tirapazamine (SR 4233)IBA
06/2011
1Oncogene Proteins (Oncogene Protein)IBA
06/2011
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2011
1HeterochromatinIBA
08/2010
1ChromatinIBA
08/2010
1EverolimusFDA Link
08/2010
1TOR Serine-Threonine KinasesIBA
08/2010
1alisol BIBA
03/2010
1SodiumIBA
11/2009
1Thrombopoietin (c-mpl Ligand)IBA
01/2008
1HLA-DQB1 antigen (HLA DQB1)IBA
07/2007
1Lamotrigine (Lamictal)FDA LinkGeneric
05/2007
1Phenytoin (Dilantin)FDA LinkGeneric
05/2007
1HLA-A*33 antigenIBA
08/2006
1HLA-B67 antigenIBA
08/2006
1HLA-B17 antigenIBA
08/2006
1Antigen-Antibody Complex (Immune Complex)IBA
04/2005

Therapy/Procedure

4Therapeutics
11/2021 - 03/2007
2Drug Therapy (Chemotherapy)
11/2021 - 12/2011
1Aftercare (After-Treatment)
01/2013
1Noninvasive Ventilation
11/2009